Eureka Globalstars Japan

28 Oct 2025 – 21 Jan 2026

PartnershipUpdated on 10 November 2025

BIOTECH: Finding funding to develop Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design

Founder & CEO at ReSynapse Therapeutics

Nes Ziona, Israel

About

We would like to find potential strategic partnership for funding a co-development of Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design, aiming for treatment-resistant depression patients.

Similar opportunities